Trulicity Dosage

Generic name: Dulaglutide 0.75mg in 0.5mL
Dosage form: injection, solution
Drug class: GLP-1 Agonists (Incretin Mimetics)

Medically reviewed by Drugs.com. Last updated on Nov 1, 2024.

The recommended starting dosage of TRULICITY is 0.75 mg injected subcutaneously once weekly. Follow the dosage escalation below to reduce the risk of gastrointestinal adverse reactions.
After 4 weeks, the dosage may be increased to 1.5 mg once weekly for additional glycemic control.
If additional glycemic control is needed, increase the dosage in 1.5 mg increments after at least 4 weeks on the current dosage.
The maximum recommended dosage is 4.5 mg injected subcutaneously once weekly.

The recommended starting dosage of TRULICITY is 0.75 mg injected subcutaneously once weekly.
If additional glycemic control is needed, increase the dosage to the maximum recommended dosage of 1.5 mg once weekly after at least 4 weeks on the 0.75 mg dosage to reduce the risk of gastrointestinal adverse reactions.

If a dose is missed, instruct patients to administer the dose as soon as possible if there are at least 3 days (72 hours) until the next scheduled dose. If less than 3 days remain before the next scheduled dose, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.
The day of weekly administration can be changed, if necessary, as long as the last dose was administered 3 or more days before the new day of administration.

Prior to initiation, train patients and caregivers on proper injection technique.
Administer TRULICITY once weekly, any time of day, with or without food.
Inject TRULICITY subcutaneously in the abdomen, thigh, or upper arm.
Rotate injection sites with each dose.
Inspect TRULICITY visually before use. It should appear clear and colorless. Do not use TRULICITY if particulate matter or coloration is seen.
When using TRULICITY with insulin, administer as separate injections and never mix. It is acceptable to inject TRULICITY and insulin in the same body region, but the injections should not be adjacent to each other.